Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
41495267
TITLE
Trans-ancestry GWAS of hot flashes reveals potent treatment target and overlap with psychiatric disorders.
ABSTRACT
BACKGROUND NlmCategory: BACKGROUND
Most women experience hot flashes (hot flushes) during the menopause transition. Menopausal hot flashes typically persist for years, and for a sizeable minority of women, are substantially impairing. Genetic investigations can improve understanding of hot flash etiology.
METHODS NlmCategory: METHODS
Most women experience hot flashes (hot flushes) during the menopause transition. Menopausal hot flashes typically persist for years, and for a sizeable minority of women, are substantially impairing. Genetic investigations can improve understanding of hot flash etiology. We conducted a trans-ancestry genome-wide association study (GWAS) of hot flashes (N = 149,560) among post-menopausal women age 35-88. The outcome variable was self-reported hot flashes in four samples (total n = 42,489) and menopausal hormone therapy as a proxy in one sample (n = 107,071). We estimated the heritability of hot flashes and genetic correlations with psychiatric phenotypes using linkage disequilibrium score regression.
RESULTS NlmCategory: RESULTS
Most women experience hot flashes (hot flushes) during the menopause transition. Menopausal hot flashes typically persist for years, and for a sizeable minority of women, are substantially impairing. Genetic investigations can improve understanding of hot flash etiology. We conducted a trans-ancestry genome-wide association study (GWAS) of hot flashes (N = 149,560) among post-menopausal women age 35-88. The outcome variable was self-reported hot flashes in four samples (total n = 42,489) and menopausal hormone therapy as a proxy in one sample (n = 107,071). We estimated the heritability of hot flashes and genetic correlations with psychiatric phenotypes using linkage disequilibrium score regression. In our trans-ancestry meta-analysis, the top locus lies on chromosome 4 in the neurokinin 3 receptor gene (TACR3, p = 7.2×10 ). We also identify another locus on chromosome 4 with top SNP rs13107507 (p = 3.5×10 ). Gene results implicate TACR3, GRID1, NUDT4, and PHF21B. SNP heritability is estimated to be 8% (h  = .08, h  = .04, se = .02). Genetic correlations are statistically significant between hot flashes and PTSD (rg = 0.25, p = 0.01), schizophrenia (rg = 0.17, p = 0.02), depression (rg = 0.21, p = 0.01), and ADHD (rg = .22, p = 0.03).
CONCLUSIONS NlmCategory: CONCLUSIONS
Most women experience hot flashes (hot flushes) during the menopause transition. Menopausal hot flashes typically persist for years, and for a sizeable minority of women, are substantially impairing. Genetic investigations can improve understanding of hot flash etiology. We conducted a trans-ancestry genome-wide association study (GWAS) of hot flashes (N = 149,560) among post-menopausal women age 35-88. The outcome variable was self-reported hot flashes in four samples (total n = 42,489) and menopausal hormone therapy as a proxy in one sample (n = 107,071). We estimated the heritability of hot flashes and genetic correlations with psychiatric phenotypes using linkage disequilibrium score regression. In our trans-ancestry meta-analysis, the top locus lies on chromosome 4 in the neurokinin 3 receptor gene (TACR3, p = 7.2×10 ). We also identify another locus on chromosome 4 with top SNP rs13107507 (p = 3.5×10 ). Gene results implicate TACR3, GRID1, NUDT4, and PHF21B. SNP heritability is estimated to be 8% (h  = .08, h  = .04, se = .02). Genetic correlations are statistically significant between hot flashes and PTSD (rg = 0.25, p = 0.01), schizophrenia (rg = 0.17, p = 0.02), depression (rg = 0.21, p = 0.01), and ADHD (rg = .22, p = 0.03). These genomic findings are consistent with independent, robust basic science research which led to a recently developed treatment for hot flashes, namely, a neurokinin 3 receptor antagonist. This non-hormonal class of hot flash drugs blocks the receptor coded for by the top locus reported here (TACR3, the neurokinin 3 receptor gene). Hot flash GWAS results provide an example of how GWAS findings can point to potent treatment targets for complex brain phenotypes.
© 2026. The Author(s).
DATE PUBLISHED
2026 Jan 06
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2024/09/27
accepted 2025/12/02
medline 2026/01/07 01:12
pubmed 2026/01/07 01:11
entrez 2026/01/06 23:27
pmc-release 2026/01/06
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Werwath KE Werwath Kathryn E KE Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Lawn RB Lawn Rebecca B RB Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Cambridge, MA, USA.
Salem MT Salem Madeleine T MT Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Li T Li Tayden T Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Mitchell BL Mitchell Brittany L BL Queensland Institute of Medical Research, Brisbane, QLD, Australia.
Shen H Shen Hanyang H Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Gordon SD Gordon Scott D SD Queensland Institute of Medical Research, Brisbane, QLD, Australia.
Kung B Kung Benson B Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Stafford C Stafford Ciera C Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Vemuri M Vemuri Mytilee M Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
Ratanatharathorn A Ratanatharathorn Andrew A Department of Epidemiology, Harvard T.H. Chan School of Public Health, Harvard University, Cambridge, MA, USA.
Meijsen J Meijsen Joeri J Institute for Biological Psychiatry, Copenhagen, Denmark.
Shadyab AH Shadyab Aladdin H AH Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
Kooperberg C Kooperberg Charles C Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Koenen KC Koenen Karestan C KC Psychiatric and Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.
Crandall CJ Crandall Carolyn J CJ Division of General Internal Medicine and Health Services Research, Dept. of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
Martin NG Martin Nicholas G NG Queensland Institute of Medical Research, Brisbane, QLD, Australia.
Duncan LE Duncan Laramie E LE Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, USA. laramied@stanford.edu.
INVESTIGATORS
JOURNAL
VOLUME: 6
ISSUE: 1
TITLE: Communications medicine
ISOABBREVIATION: Commun Med (Lond)
YEAR: 2026
MONTH: Jan
DAY: 06
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 2730-664X
ISSNTYPE: Electronic
MEDLINE JOURNAL
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
COMMENTS AND CORRECTIONS
GRANTS
GRANTID AGENCY COUNTRY
R01 MH123486 NIMH NIH HHS United States
R01 CA067262 NCI NIH HHS United States
U01 CA176726 NCI NIH HHS United States
R21 MH125358 NIMH NIH HHS United States
UM1 CA186107 NCI NIH HHS United States
MH125358 U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
R01 CA049449 NCI NIH HHS United States
GENERAL NOTE
KEYWORDS
MESH HEADINGS
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
OTHER ID's